title: Update on retinal detachment surgery.
abstract: OBJECTIVE
  Update on controversies in the surgical management of rhegmatogenous retinal detachment.
  
  
  RESULTS
  There are multiple new reports regarding the development and management of retinal detachment. Current use of oral fluoroquinolones may be associated with onset of retinal detachment, although the clinical relevance of this correlation is uncertain at this time and the finding has not been replicated in subsequent studies. Pars plana vitrectomy (PPV) continues to demonstrate efficacy as a primary treatment for retinal detachment, especially in pseudophakic patients. In many patients with macula-on retinal detachment, scheduling surgery after a short time delay is not necessarily deleterious and may actually be beneficial. Novel surgical tools, including bioerodible scleral buckling materials and artificial vitreous substitutes, are being investigated.
  
  
  CONCLUSIONS
  Retinal detachment remains an important cause of visual loss. Although current surgical techniques demonstrate high rates of anatomic and visual success, further advances will probably benefit patients with retinal detachment.
authors: Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17 Street, Miami, FL 33136, USA.
authors: Stephen G
authors: SG
authors: Schwartz
authors: Harry W
authors: HW
authors: Flynn
authors: William F
authors: WF
authors: Mieler
mesh_terms: D006801:Humans; D019591:Pseudophakia / Q000150:complications; D012163:Retinal Detachment / Q000601:surgery*; D012591:Scleral Buckling / Q000379:methods; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods